These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6156490)

  • 1. [Structure and biological properties of immunoglobulins and gamma-globulin preparations. II. Properties of gamma-globulin preparations].
    Morell A; Skvaril F
    Schweiz Med Wochenschr; 1980 Jan; 110(3):80-5. PubMed ID: 6156490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations].
    Barandun S; Skvaril F; Morell A
    Schweiz Med Wochenschr; 1976 Apr; 106(16):533-42. PubMed ID: 62393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclasses in human gamma-globulin preparations for intravenous use and their reactivity with staphylococcus protein A.
    Skvaril F; Roth-Wicky B; Barandun S
    Vox Sang; 1980; 38(3):147-55. PubMed ID: 6155736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic properties, aggregate content and half-life of various human i.v. gamma globulin preparations].
    Ring J; Duswald KH; Seifert J; Brendel W
    Langenbecks Arch Chir; 1976; Suppl():63-7. PubMed ID: 73997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapy with immunoglobulins. Structure, mechanisms of action and the intravenous use of gammaglobulin preparations (author's transl)].
    Schulte-Wissermann H; Schofer O; Dinkel E
    Immun Infekt; 1982 May; 10(3):98-109. PubMed ID: 6178676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of administration of gamma globulin preparations in patients with primary agammaglobulinemia].
    Litzman J; Wiedermannová D; Lokaj J; Král V
    Vnitr Lek; 1992 May; 38(5):490-4. PubMed ID: 1380749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of intravenous gammaglobulin in bacterial infections in Surgical Patients. Results of a controlled, randomized clinical study (author's transl)].
    Duswald KH; Müller K; Seifert J; Ring J
    MMW Munch Med Wochenschr; 1980 May; 122(22):832-5. PubMed ID: 6156412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-verotoxin-neutralizing antibody in intravenous gammaglobulin preparations].
    Adachi E; Yoshino K; Kimura T; Matsumoto Y; Takeda T
    Kansenshogaku Zasshi; 1998 Aug; 72(8):808-12. PubMed ID: 9780583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gammaglobulin preparations used for treatment of primary humoral immunodeficiencies].
    Bernatowska E
    Postepy Hig Med Dosw; 2002; 56 Suppl():23-31. PubMed ID: 12661411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of human gamma globulin in the treatment of common variable immunodeficiency].
    de Gracia J; Vendrell M; Guarner L; Vidal R; Miravitlles M; Mayordomo C; Morell F
    Med Clin (Barc); 1995 Feb; 104(6):201-6. PubMed ID: 7534366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On gamma globulin therapy. The development of gamma globulin preparations for intravenous injection].
    Riva G
    Helv Med Acta; 1963 Nov; 30(4):277-90. PubMed ID: 4168346
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of IgG subclasses in commercial and some experimental gamma-globulin preparations.
    Skvaril F; Probst M; Audran R; Steinbuch M
    Vox Sang; 1977; 32(6):335-8. PubMed ID: 70884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of antitoxin and antibacterial activity of human preparations of normal immunoglobulin. I. Level of tetanus antitoxin in preparations of IMIG and IVIG].
    Zakrzewska A; Rymkiewicz D
    Przegl Epidemiol; 1995; 49(4):381-4. PubMed ID: 8868196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo behaviour of gamma globulin preparations.
    Morell A; Schürch B; Ryser D; Hofer F; Skvaril F; Barandun S
    Vox Sang; 1980; 38(5):272-83. PubMed ID: 6158170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of non-enzymatic desamidation of gamma-globulin on its properties and biological activity].
    Lukash AI; Shepelev AP; Pushkina NV; Tsybul'skiĭ IE; Al'perovich DV
    Vopr Med Khim; 1985; 31(4):104-8. PubMed ID: 2413619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections].
    Duswald KH; Ring J
    Klin Anasthesiol Intensivther; 1980; 21():207-23. PubMed ID: 6161270
    [No Abstract]   [Full Text] [Related]  

  • 17. [The primary interaction with DNA of "latent high-avidity antibodies" from gamma-globulin preparations, probably, is determined by the presence of a cofactor].
    Saenko VA; Poverennyĭ AM
    Biull Eksp Biol Med; 1993 Jun; 115(6):624-5. PubMed ID: 7690615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to meningococcus polysaccharides in nonspecific gamma-globulins from different regions of the world.
    Demina AA; Samsonova IM; Fayet MT; Béranger J; Gibilin N; Plan R; Triau R
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):437-44. PubMed ID: 6198376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of gammaglobulin preparations on in vitro immunoglobulin production induced by pokeweed mitogen].
    Hashimoto F
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):64-71. PubMed ID: 6201426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura.
    Tsubakio T; Kurata Y; Katagiri S; Kanakura Y; Tamaki T; Kuyama J; Kanayama Y; Yonezawa T; Tarui S
    Clin Exp Immunol; 1983 Sep; 53(3):697-702. PubMed ID: 6193913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.